Shinpoong Pharmaceutical Co., Ltd.
Shinpoong Pharmaceutical Co., Ltd. (KRX: 019170) is trading at ₩9,780.00, about ₹706 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 11.17% today. Shinpoong Pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩9,750.00
Today's high
₩10,130.00
52 week low
₩6,310.00
52 week high
₩15,900.00
019170 opened at ₩10,110.00, closed previously at ₩11,010.00, and has traded between ₩6,310.00 and ₩15,900.00 over the past 52 weeks.
About
Shinpoong Pharmaceutical Co., Ltd. is a South Korean company that manufactures and distributes a broad spectrum of pharmaceutical products. Its portfolio includes both cephalosporin and penicillin antibiotics, alongside other finished medications. The company also produces active pharmaceutical ingredients (APIs) and offers specialized drugs such as Pyramax, an anti-malarial treatment, as well as therapies for hypercholesterolemia, knee osteoarthritis, shoulder periarthritis, and surgical adhesion prevention. Furthermore, they market various over-the-counter (OTC) products. Founded in 1962 and headquartered in Seoul, South Korea, Shinpoong Pharmaceutical extends its market reach internationally, exporting its goods to roughly 50 countries.
Key statistics
Avg. volume
338.57K
Market cap
₩505.71B
P/E Ratio
-1024.08
Price-to-sales ratio
2.12
Enterprise value
₩783.22B
Free cash flow yield
1.78%
Debt-to-equity ratio
0.19
Return on equity
3.27%
ROIC
4.29%
Beta
1.12
Dividend yield
0.00%
Last dividend
₩0.00
Financial overview
Revenue
₩234.68B
Earnings per share
₩172.00
Free cash flow
₩13.78B
Net profit margin
-0.34%
Gross margin
42.36%
EBITDA
₩25.65B
Revenue growth
6.15%
Similar securities
This is not an investment recommendation
Shinpoong Pharmaceutical for Indian investors
Shinpoong Pharmaceutical is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Shinpoong Pharmaceutical for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneShinpoong Pharmaceutical does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy Shinpoong Pharmaceutical on Paasa?
Shinpoong Pharmaceutical (019170) has been listed on the Korea Exchange since 1991, in the Drug Manufacturers - Specialty & Generic industry. Shinpoong Pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Shinpoong Pharmaceutical share cost in rupees?
One Shinpoong Pharmaceutical share is ₩9,780.00 — about ₹706 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Shinpoong Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Shinpoong Pharmaceutical shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Shinpoong Pharmaceutical price.
Does Shinpoong Pharmaceutical pay a dividend?
No. Shinpoong Pharmaceutical does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Shinpoong Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Shinpoong Pharmaceutical?
Yes. Shinpoong Pharmaceutical is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.